Re: An example of how "safe" Bush really kept you

On Fri, 1 May 2009 20:21:45 -0700 (PDT), Too_Many_Tools
<too_many_tools@xxxxxxxxx> wrote:

Actions speak louder than words.

The fact that the Country is vastly unprepared with flu-treatment
doses indicates that the former Bush Administration was more talk than
action.

Horse*** (as usual from you).

It was Bush who put into place the stockpile program for the
anti-virals that are now being distrubuted to the States:

http://online.wsj.com/article/SB124087436467761251.html

Do you sit around making this *** up just because you want it to be
true?

Fuckin' dim bulb.



Considering it might mean the life and death of your family, it is a
fact that you may want to remember the next time a Republican wants
your vote.

TMT


Survey: Fewer than half the U.S. states have enough flu treatment drug
stockpiled

By Alex Dominguez

Associated Press

BALTIMORE ? With a swine flu outbreak spreading across the nation,
more than half the states have yet to stockpile the number of flu-
treatment doses recommended by the federal government, an Associated
Press survey found.

States that are falling short cite budget constraints, or say it's
better to spend health-care funds on preventing the spread of disease
than on antiviral medicines that may or may not work on a particular
flu strain.

"You don't have any guarantee that if you purchase a large amount of
drugs that they would be effective in the future," said Gwenda Bond, a
spokeswoman for the Kentucky Cabinet for Health and Family Services.
"Drugs do have a shelf life, and so you don't want to spend a lot of
money on drugs that may expire before you need them."

The strain of swine flu that began appearing in Mexico and has since
spread to 19 U.S. states is treatable ? but not preventable ? using
Tamiflu and Relenza, each of which has a shelf life of about five
years.

The U.S. Department of Health and Human Services recommends that each
state have enough antiviral medicine on hand to treat 25 percent of
its population. But an AP survey of all 50 states and the District of
Columbia found that 29 were below that threshold.

Several were just under it, but 15 states had enough medicine on hand
to treat fewer than 20 percent of residents. Seven states ? Arizona,
Colorado, Connecticut, Florida, Idaho, Massachusetts and Montana ?
could treat about 15 percent.

Despite that, the acting head of the U.S. Centers for Disease Control
and Prevention said no state is expected to experience shortages
because the federal government is racing to fill states' stockpiles
with millions of additional doses from its own strategic reserves.

Dr. Richard Besser said Thursday that the CDC had deployed drugs to
nine states so far, and that all 50 states would receive allocations
from the national reserve by Sunday.

Besser said the deployment is being done "as a forward-leaning
move ... in case this becomes something much bigger than it currently
is."

Federal officials also said there was no shortage of the medicine in
regular pharmacies.

A course of antiviral medicine contains enough doses to treat one
person. In 2006, as part of its own pandemic flu preparations, the
federal government created a stockpile of 44 million courses, which
would cover about 15 percent of the U.S. population.

It then recommended that states purchase additional courses so the
combined stockpiles would cover one quarter of each state's
population, and offered subsidies covering 25 percent of the cost.
Because some states passed on the subsidies, other states were able to
use the federal aid to go beyond 25 percent coverage.

The AP's tally includes both drugs currently on hand in the states and
those expected over the next week or so from the Centers for Disease
Control and the drugs' manufacturers.

Hawaii has enough for nearly 29 percent of its population. It bought
more than the recommended amount because of the year-round stream of
tourists who boost its population.

Bill Hall, a spokesman for the Department of Health and Human
Services, said the federal government based the 25 percent figure on
past pandemic outbreaks in which about a quarter of the population
became infected and "made it clear this is shared responsibility with
the states."

The swine flu outbreak is a road test of sorts for battling an
outbreak with antiviral medicine, said Trish Perl, an infectious
disease expert at the Johns Hopkins University School of Public
Health.

"None of us have ever really done this practically," she said. "Right
now is the first time that we've been able to really test it with some
of the prevention strategies that have been used in states where they
have had some of these cases. So, I think the good news is that we're
going to know relatively soon."

However, the drugs' effectiveness is limited. Tamiflu, the more
commonly stocked of the drugs, needs to be taken within in first 48
hours of the onset of symptoms, according to its manufacturer, The
Roche Group. It generally only reduces the duration of symptoms.

Georgia Gov. Sonny Perdue had originally proposed spending $15.7
million for about 2.2 million courses in 2007, but the spending was
cut to $7 million by state lawmakers and the state ended up purchasing
460,000 courses instead. Combined with the 1.3 million currently
allocated by the federal government to Georgia, that's enough to cover
about 18 percent of the state's population of 9.7 million.

Kentucky health officials' decision to get half the amount recommended
under the federal guidelines came down to both a policy and financial
decision, Bond said. Health officials did not want to buy too much
medication that may not be able to treat a pandemic or could
eventually expire and go to waste.

"But at the same time, we did feel that it was prudent to ... have
some on hand, because they are effective against many flu strains,"
she said.

So Kentucky spent about $3.6 million on antiviral courses, which is
"no small expense" for a state that's facing massive budget woes, Bond
said. Kentucky has enough to cover just over 20 percent of its
population.

Colorado and Maine are among the states that chose not to stockpile
treatments, deciding the money would be better spent on hygiene
education, canceling large gatherings and other precautions against a
pandemic flu.

"Since this is the biggest gain for the dollar, this is where we have
put our efforts," said Chris Lindley, division director for the
Colorado Department of Public Health and Environment.

In Massachusetts, where the state has enough antivirals to treat
slightly more than 15 percent of the population, health department
spokeswoman Jennifer Manley said the state's decision not to buy the
recommended amount was based in part on the fact the state had to pay
out of pocket for the drugs and if a virus becomes resistant, the
antiviral courses would be wasted.

"It's not a silver bullet," Manley said. "If we ordered a million
doses, and it becomes resistant, that is a lot."

Hall, the HHS spokesman, said the federal government left it up to the
states to decide whether they needed to purchase the full amount
available to them, and some opted against it.

Jeff Levi of the Trust for America's Health, which compiled a recent
state-by-state report on the stockpiling of antiviral medicine,
criticized that decision and said the federal government should have
purchased the full amount itself.

"I think what we're seeing with swine flu, with the virus being
susceptible to the drugs in the stockpile, I think it demonstrates the
importance of doing this," Levi said.

???

Associated Press writers Joe Biesk in Frankfort, Ky.; Steve LeBlanc in
Boston; Shannon McCaffrey in Atlanta; Malcolm Ritter in New York; and
Kristen Wyatt in Denver contributed to this story.
.